Return of the metabolic trajectory to the original area after human bone marrow mesenchymal stem cell transplantation for the treatment of fulminant hepatic failure

Journal of Proteome Research

Volumn 11, Issue 6, 2012, Pages 3414-3422

  Li, Jun ^a   Xin, Jiaojiao ^a   Hao, Shaorui ^a   Zhang, Liyuan ^a   Jiang, Longyan ^a   Chen, Deying ^a   Xie, Qing ^a   Xu, Wei ^a   Cao, Hongcui ^a   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

fulminant hepatic failure; human bone marrow mesenchymal stem cells; metabolic profiling; transplantation

Indexed keywords

1 ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE; ALANINE AMINOTRANSFERASE; AMINO ACID; AMMONIA; BILE ACID CONJUGATE; BILIRUBIN; FATTY ACID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPASE A1; SPHINGOMYELIN; BIOLOGICAL MARKER; LYSOPHOSPHOLIPASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL PIG; FULMINANT HEPATIC FAILURE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME; REPRODUCIBILITY; SURVIVAL; ANIMAL; BLOOD; BONE MARROW CELL; GENETICS; LIVER; LIVER FAILURE, ACUTE; LIVER REGENERATION; PATHOLOGY; PHYSIOLOGY; SWINE; TREATMENT OUTCOME;

SUIDAE;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; GENE EXPRESSION; HUMANS; LIVER; LIVER FAILURE, ACUTE; LIVER REGENERATION; LYSOPHOSPHOLIPASE; MESENCHYMAL STEM CELL TRANSPLANTATION; REPRODUCIBILITY OF RESULTS; SUS SCROFA; TREATMENT OUTCOME;

EID: 84861810408     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3002639     Document Type: Article

References (33)

1. Hoofnagle, J. H.; Carithers, R. L., Jr.; Shapiro, C.; Ascher, N. Fulminant hepatic failure: summary of a workshop Hepatology 1995, 21 (1) 240-52
2. Fox, I. J.; Roy-Chowdhury, J. Hepatocyte transplantation J. Hepatol. 2004, 40 (6) 878-86
3. Oertel, M.; Shafritz, D. A. Stem cells, cell transplantation and liver repopulation Biochim. Biophys. Acta 2008, 1782 (2) 61-74
4. Almeida-Porada, G.; Zanjani, E. D.; Porada, C. D. Bone marrow stem cells and liver regeneration Exp. Hematol. 2010, 38 (7) 574-80
5. Gilchrist, E. S.; Plevris, J. N. Bone marrow-derived stem cells in liver repair: 10 years down the line Liver Transplant. 2010, 16 (2) 118-29
6. Yanes, O.; Clark, J.; Wong, D. M.; Patti, G. J.; Sanchez-Ruiz, A.; Benton, H. P.; Trauger, S. A.; Desponts, C.; Ding, S.; Siuzdak, G. Metabolic oxidation regulates embryonic stem cell differentiation Nat. Chem. Biol. 2010, 6 (6) 411-7
7. Yu, K.; Sheng, G.; Sheng, J.; Chen, Y.; Xu, W.; Liu, X.; Cao, H.; Qu, H.; Cheng, Y.; Li, L. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus J. Proteome Res. 2007, 6 (7) 2413-9
8. Zhou, P.; Li, J.; Shao, L.; Lv, G.; Zhao, L.; Huang, H.; Zhang, A.; Pan, X.; Liu, W.; Xie, Q.; Chen, D.; Guo, Y.; Hao, S.; Xu, W.; Li, L. Dynamic Patterns of serum metabolites in fulminant hepatic failure pigs Metabolomics 2011, 10.1007/s11306-011-0381-5
9. Li, J.; Zhang, L.; Xin, J.; Jiang, L.; Zhang, T.; Jin, L.; Zhou, P.; Hao, S.; Cao, H.; Li, L. Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs Hepatology 2012, 10.1002/hep.25722
10. Lv, G.; Zhao, L.; Zhang, A.; Du, W.; Chen, Y.; Yu, C.; Pan, X.; Zhang, Y.; Song, T.; Xu, J.; Li, L. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs Biotechnol. Bioeng. 2011, 108 (9) 2229-36
11. Cezar, G. G.; Quam, J. A.; Smith, A. M.; Rosa, G. J.; Piekarczyk, M. S.; Brown, J. F.; Gage, F. H.; Muotri, A. R. Identification of small molecules from human embryonic stem cells using metabolomics Stem Cells Dev. 2007, 16 (6) 869-82
12. Turner, W. S.; Seagle, C.; Galanko, J. A.; Favorov, O.; Prestwich, G. D.; Macdonald, J. M.; Reid, L. M. Nuclear magnetic resonance metabolomic footprinting of human hepatic stem cells and hepatoblasts cultured in hyaluronan-matrix hydrogels Stem Cells 2008, 26 (6) 1547-55
13. Paik, M. J.; Li, W. Y.; Ahn, Y. H.; Lee, P. H.; Choi, S.; Kim, K. R.; Kim, Y. M.; Bang, O. Y.; Lee, G. The free fatty acid metabolome in cerebral ischemia following human mesenchymal stem cell transplantation in rats Clin. Chim. Acta 2009, 402 (1-2) 25-30
14. Keppler, D.; Decker, K. Studies on the mechanism of galactosamine-1- phosphate and its inhibition of UDP-glucose pyrophosphorylase Eur. J. Biochem. 1969, 10 (2) 219-25
15. Keppler, D. O.; Rudigier, J. F.; Bischoff, E.; Decker, K. F. The trapping of uridine phosphates by d -galactosamine. d -glucosamine, and 2-deoxy- d -galactose. A study on the mechanism of galactosamine hepatitis Eur. J. Biochem. 1970, 17 (2) 246-53
16. El-Mofty, S. K.; Scrutton, M. C.; Serroni, A.; Nicolini, C.; Farber, J. L. Early, reversible plasma membrane injury in galactosamine-induced liver cell death Am. J. Pathol. 1975, 79 (3) 579-96
17. Kuo, T. K.; Hung, S. P.; Chuang, C. H.; Chen, C. T.; Shih, Y. R.; Fang, S. C.; Yang, V. W.; Lee, O. K. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells Gastroenterology 2008, 134 (7) 2111-21 and e1-3
18. Miyazaki, M.; Hardjo, M.; Masaka, T.; Tomiyama, K.; Mahmut, N.; Medina, R. J.; Niida, A.; Sonegawa, H.; Du, G.; Yong, R.; Takaishi, M.; Sakaguchi, M.; Huh, N. H. Isolation of a bone marrow-derived stem cell line with high proliferation potential and its application for preventing acute fatal liver failure Stem Cells 2007, 25 (11) 2855-63
19. Campollo, O.; Sprengers, D.; McIntyre, N. The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics Rev. Invest. Clin. 1992, 44 (4) 513-8
20. Dejong, C. H.; van de Poll, M. C.; Soeters, P. B.; Jalan, R.; Olde Damink, S. W. Aromatic amino acid metabolism during liver failure J. Nutr. 2007, 137 (6 Suppl 1) 1579S-85S discussion 1597S-1598S
21. Hao, S.; Xin, J.; Lian, J.; Xie, Q.; Chen, D.; Guo, Y.; Lu, Y.; Sheng, G.; Xu, W.; Huang, J.; Li, L. Establishing a metabolomic model for the prognosis of hepatitis B virus-induced acute-on-chronic liver failure treated with different liver support systems Metabolomics 2011, 7 (3) 400-12
22. Clemmesen, J. O.; Hoy, C. E.; Jeppesen, P. B.; Ott, P. Plasma phospholipid fatty acid pattern in severe liver disease J. Hepatol. 2000, 32 (3) 481-7
23. Pollesello, P.; Eriksson, O.; Hockerstedt, K. Analysis of total lipid extracts from human liver by 13C and 1H nuclear magnetic resonance spectroscopy Anal. Biochem. 1996, 236 (1) 41-8
24. Richmond, G. S.; Smith, T. K. Phospholipases a(1) Int. J. Mol. Sci. 2011, 12 (1) 588-612
25. Lands, W. E. Metabolism of glycerolipids. 2. The enzymatic acylation of lysolecithin J. Biol. Chem. 1960, 235, 2233-7
26. Agirbasli, D.; Cirakoglu, B.; Eren, F.; Sumerkan, M.; Aksoy, S.; Aral, C.; Agirbasli, M. Effects of lecithin: cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels J. Clin. Lipidol. 2011, 5 (3) 152-8
27. Buckley, J. T.; Halasa, L. N.; MacIntyre, S. Purification and partial characterization of a bacterial phospholipid: cholesterol acyltransferase J. Biol. Chem. 1982, 257 (6) 3320-5
28. Tanaka, T.; Ikeda, K.; Yamamoto, Y.; Iida, H.; Kikuchi, H.; Morita, T.; Yamasoba, T.; Nagai, R.; Nakajima, T. Effects of serum amyloid a and lysophosphatidylcholine on intracellular calcium concentration in human coronary artery smooth muscle cells Int. Heart J. 2011, 52 (3) 185-93
29. Aiyar, N.; Disa, J.; Ao, Z.; Ju, H.; Nerurkar, S.; Willette, R. N.; Macphee, C. H.; Johns, D. G.; Douglas, S. A. Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells Mol. Cell. Biochem. 2007, 295 (1-2) 113-20
30. Schmitz, G.; Ruebsaamen, K. Metabolism and atherogenic disease association of lysophosphatidylcholine Atherosclerosis 2010, 208 (1) 10-8
31. Hasegawa, H.; Lei, J.; Matsumoto, T.; Onishi, S.; Suemori, K.; Yasukawa, M. Lysophosphatidylcholine enhances the suppressive function of human naturally occurring regulatory T cells through TGF-beta production Biochem. Biophys. Res. Commun. 2011, 415 (3) 526-31
32. Wang, Q.; Wu, Y. J. Lysophosphatidylcholine induces Ca(2+) mobilization in Jurkat human T lymphocytes and CTLL-2 mouse T lymphocytes by different pathways Eur. J. Pharm. Sci. 2011, 44 (5) 602-9
33. Burdon, T. J.; Paul, A.; Noiseux, N.; Prakash, S.; Shum-Tim, D. Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential Bone Marrow Res. 2011, 2011, 207326